PET2015UZ: Breast cancer preoperative 18 FDG-PET, cohort 2002-2008.

Published: 25 October 2021| Version 2 | DOI: 10.17632/sfvtmrd8z9.2
Vincent Vinh-Hung


Data referred to in manuscripts: ### Breast cancer preoperative 18FDG-PET, overall survival prognostic separation # compared with the lymph node ratio. # Vinh-Hung V, Everaert H, Gorobets O, Van Parijs H, Verfaillie G, Vanhoeij M, # Storme G, Fontaine C, Lamote J, Perrin J, Farid K, Nguyen NP, # Verschraegen C, De Ridder M. # Breast Cancer. 2021 Jul;28(4):956-968. doi: 10.1007/s12282-021-01234-z # PMID: 33689151 # ### Is there a utility of [18F]FDG-PET before surgery in breast cancer? # A 15-years overall survival analysis. # Perrin, Farid K, Van Parijs H, Gorobets O, Vinh-Hung V, Nguyen NP, # Djassemi N, De Ridder M, Everaert H. # World J Clin Oncol. Pending. Code referred to in manuscript: ### Lymph Node Ratio after Neoadjuvant Chemotherapy for Stage II/III Breast Cancer: # Prognostic Value Measured with Gini’s Mean Difference of Restricted Mean Survival Times. # Keam B, Gorobets O, Vinh-Hung V, Im SA. # Cancer Informatics. 2021. # doi: 10.1177/117693512110516 <== incorrect # errata October 23, 2021, the correct DOI is: # DOI: 10.1177/11769351211051675 File with the deidentified data: listpet2020jan31_anonym3.xlsx The file contains SUV data for 36 patients. Software file rankit_gmd_D-measure_04 contains R functions for use with the dataset: rnkttb, computes scaled rankit transforms; Dm, Royston-Sauerbrei measure of prognostic separation; r2d, a measure of explained variation based on the D measure of separation; r2n, Nagelkerke proportion of explained variation; gmd, computes Gini's mean difference


Steps to reproduce

Protocol detailed in: Registered in:


Universitair Ziekenhuis Brussel


Positron Emission Tomography, Breast Cancer, Predictive Factor, Cancer Staging, Prognostic Factor for Breast Cancer, Biomarker in Prognosis